Abstract
Intramyocardial transplantation of autologous bone marrow mononuclear cells (BMMC) is believed to be a promising method for the treatment of patients with chronic ischemic heart disease. The aim of this study was to evaluate long-term results of intramyocardial bone marrow cell transplantation in patients with severe ischemic heart failure. One hundred nine patients with chronic myocardial infarction and end-stage chronic heart failure were randomized into two groups: 55 patients received intramyocardial BMMC injection and 54 received optimal medical therapy. The NOGA system (Biosense-Webster) was used to administer 41 ± 16 × 106 BMMC into the border zone of myocardial infarction. None of the patients developed periprocedural complications following BMMC injections. The injections led to improvement of CCS class (3.1 ± 0.4 to 1.6 ± 0.6 after 6 months and 1.6 ± 0.4 after 12 months; p = 0.001) and NYHA functional class (3.3 ± 0.2 to 2.3 ± 0.2 after 6 months and 2.5 ± 0.1 after 12 months; p = 0.006). Left ventricular ejection fraction increased significantly in the BMMC group (27.8 ± 3.4% vs 32.3 ± 4.1%; p = 0.04) while it tended to decrease in the control group (26.8 ± 3.8% to 25.2 ± 4.1%; p = 0.61). Summed rest score improved in the BMMC group after 12 months (30.2 ± 5.6 to 27.8 ± 5.1; p = 0.032). The improvement of stress score was more noticeable (34.5 ± 5.4 to 28.1 ± 5.2; p = 0.016). Neither stress nor rest score changed in patients numbers on medical therapy. In BMMC group 6 (10.9%) patients died at 12-month follow-up compared with 21 (38.9%) in control group (log-rank test, p = 0.0007). Intramyocardial bone marrow cell transplantation to patients with ischemic heart failure is safe and improved survival, clinical symptoms, and has beneficial effect on LV function
Similar content being viewed by others
References
Tse, H. F. Kwong, Y. L. Chan, J. K. Lo, G. Ho, C. L. & Lau, C. P. (2003). Angiogenesis in ischemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet, 361, 47–49.
Fuchs, S. Satler, L. F. Kornowski, R. et al. (2003). Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease. Journal of the American College of Cardiology, 41, 1721–1724.
Perin, E. C. Dohmann, H. F. Borojevic, R. et al. (2003). Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation, 107, 2294–2302.
Perin, E. C. Dohmann, H. F. Borojevic, R. et al. (2004). Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation, 110(suppl II), II-213–II-218.
Beeres, S. Bax, J. Dibbets, P. Stokkel, M. Zeppenfeld, K. et al. (2006). Effect of intramyocardial injection of autologous bone marrow—derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia. Journal of Nuclear Medicine, 47, 574–580.
Perin, E. C. Silva, G. V. Sarmento-Leite, R. Sousa, A. L. Howell, M. et al. (2002). Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: Validation by delayed-enhancement magnetic resonance imaging. Circulation, 106, 957–961.
Wrobleski, D. Houghtaling, C. Josephson, M. E. Ruskin, J. N. & Reddy, V. Y. (2003). Use of electrogram characteristics during sinus rhythm to delineate the endocardial scar in a porcine model of healed myocardial infarction. Journal of Cardiovascular Electrophysiology, 14, 524–529.
Marchlinski, F. E. Callans, D. J. Gottlieb, C. D. & Zado, E. (2000). Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation, 101, 1288–1296.
Ben-Haim, S. A. Osadchy, D. Schuster, I. Gepstein, L. Hayam, G. et al. (1996). Nonfluoroscopic, in vivo navigation and mapping technology. Nature Medicine, 2, 1393–1395.
Gepstein, L. Hayam, G. & Ben-Haim, S. A. (1997). A novel method for nonfluoroscopic catheterbased electroanatomical mapping of the heart. In vitro and in vivo accuracy results. Circulation, 95, 1611–1622.
Berman, D. S. Hachamovitch, R. Kiat, H. Cohen, I. Cabico, J. A. et al. (1995). Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. Journal of the American College of Cardiology, 26, 639–647.
Liu, Y. Guo, J. Zhang, P. et al. (2004). Bone marrow mononuclear cell transplantation into heart elevates the expression of angiogenic factors. Microvascular Research, 68, 156–160.
Orlic, D. Hill, J. & Arai, A. (2002). Stem cells for myocardial regeneration. Circulation Research, 91, 1092–1102.
Silva, G. Perin, E. Dohmann, H. Borojevic, R. Silva, S. et al. (2004). Catheter-based transendocardial delivery of autologous bone-marrow-derived mononuclear cells in patients listed for heart transplantation. Texas Heart Institute, 31, 214–219.
Dohmann, H. Silva, S. Souza, A. Rossi, M. Takiya, C. & Borojevic, R. (2007). Bone-marrow mononuclear cell therapy of severe ischemic heart failure. C. R. Biologies, 330, 543–549.
Fuchs, S. Satler, L. Kornowski, R. Okubagzi, P. Weisz, G. et al. (2003). Catheter-based autologous bone marrow myocardial injection in nooption patients with advanced coronary artery disease: A feasibility study. Journal of the American College of Cardiology, 41, 1721–1724.
Fuchs, S. Kornowski, R. Weisz, G. Satler, L. Smits, P. et al. (2006). Safety and feasibility of transendocardial autologous bone-marrow cell transplantation in patients with advanced heart disease. American Journal of Cardiology, 97, 823–829.
Beeres, S. Bax, J. Dibbets-Schneider, P. Stokkel, M. Fibbe, W. et al. (2006). Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: Twelve-month follow-up results. American Heart Journal, 152, 11–16.
Izawa, H. Kondo, T. Usui, A. Yamamoto, K. Shintani, S. et al. (2006). Clinical protocol for angiogenesis by intramyocardial injection of autologous bone marrow mononuclear cells in patients with severe coronary artery disease. Circ. J, 70, 1180–1183.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pokushalov, E., Romanov, A., Chernyavsky, A. et al. Efficiency of Intramyocardial Injections of Autologous Bone Marrow Mononuclear Cells in Patients with Ischemic Heart Failure: A Randomized Study. J. of Cardiovasc. Trans. Res. 3, 160–168 (2010). https://doi.org/10.1007/s12265-009-9123-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-009-9123-8